...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Resistance to beta-Lactamase Inhibitor Protein Does Not Parallel Resistance to Clavulanic Acid in TEM beta-Lactamase Mutants.
【24h】

Resistance to beta-Lactamase Inhibitor Protein Does Not Parallel Resistance to Clavulanic Acid in TEM beta-Lactamase Mutants.

机译:对β-内酰胺酶抑制剂蛋白的抗性与TEMβ-内酰胺酶突变体对棒酸的抗性并不平行。

获取原文
获取原文并翻译 | 示例

摘要

In order to compare patterns of resistance to inhibition by clavulanic acid with patterns of resistance to inhibition by a beta-lactamase inhibitor protein (BLIP), R164S, R244S, and R164S/R244S mutant forms of TEM beta-lactamase were prepared by site-directed mutagenesis. When kinetic parameters were determined for these mutant and wild-type forms of TEM, the single mutants showed properties that were similar to those in the literature but the double mutant showed properties that were very different. The R164S/R244S double mutant form of TEM retained its resistance to inhibition by clavulanic acid (characteristic of the R244S mutation) but lost all its ability to hydrolyze ceftazidime (characteristic of the R164S mutation). While these characteristics are contrary to those previously reported for an R164S/R244S double mutant, this discrepancy resulted from the use of a defective mutant in the earlier study. Both the single and double mutant forms of TEM remained highly sensitive when tested for inhibition by BLIP, showing only slightly increased resistance compared to that of the wild type; this pattern of resistance is quite different from the pattern of clavulanic acid resistance. The slight increases in resistance to inhibition by BLIP seen in the mutants may have been related to the fact that all of the mutations effected changes in the net charge on the TEM protein that could impede interactions with BLIP.
机译:为了比较棒棒酸的抗药性和β-内酰胺酶抑制剂蛋白(BLIP)的抗药性,通过定点制备了R164S,R244S和R164S / R244S突变型的TEMβ-内酰胺酶。诱变。当确定了这些突变体和野生型TEM的动力学参数时,单个突变体显示出与文献中相似的特性,而双突变体显示出非常不同的特性。 TEM的R164S / R244S双重突变体形式保持了其对棒酸抑制的抵抗力(R244S突变的特征),但失去了水解头孢他啶的所有能力(R164S突变的特征)。尽管这些特征与先前报道的R164S / R244S双重突变体的特征相反,但这种差异是由于在较早的研究中使用有缺陷的突变体引起的。当测试通过BLIP抑制时,TEM的单突变体和双突变体形式均保持高度敏感,与野生型相比,仅显示出略微增加的抗性。这种抗药性与棒酸抗药性大不相同。在突变体中发现的对BLIP抑制的抵抗力的轻微增加可能与以下事实有关,即所有突变均影响TEM蛋白上净电荷的变化,从而可能阻碍与BLIP的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号